We are international

Myeloma Minute
January 22, 2015
January 22, 2015
Share the Minute Facebook Tweet!
Donate to the IMF


This week's question: If bone density is low, does that mean myeloma is present?


Multiple Myeloma Bone Study



 Upcoming Events


Saturday, March 7, 2015
Regional Community Workshop Denver, Colorado


Saturday, March 14, 2015
Regional Community Workshop San Diego, California


Watch the IMF Mambo for Myeloma & Support This Challenge




New IMWG Guidelines on the Role of MRI in Myeloma


This week, the IMF’s research division, the International Myeloma Working Group (IMWG), published guidelines in the Journal of Clinical Oncology on the use of MRI (magnetic resonance imaging) in myeloma. The IMWG guidelines recommend that all patients with smoldering or asymptomatic myeloma undergo whole-body MRI, or spine and pelvic MRI if whole body MRI is not available. This recommendation is in sync with the IMWG’s “New Diagnostic Criteria” for myeloma, published in November in the Lancet Oncology, in which the presence of more than one MRI lesion is identified as a basis for considering starting full anti-myeloma therapy. The guidelines note that MRI at diagnosis of symptomatic patients (based upon presence of CRAB criteria) provides prognostic information but does not change treatment selection. The IMF’s IMWG is the leader in developing guidelines for the diagnosis, monitoring, and treatment of myeloma. CLICK HERE to read the guidelines. CLICK HERE to watch IMF Chairman Dr. Brian Durie explain the importance of MRI in smoldering myeloma in #AskDrDurie.


Reminder: February 2015 IMF Patient & Family Seminar Set for Boca Raton


The first Patient & Family Seminar for 2015 will return to Boca Raton, Florida from February 13 to February 14, 2015. The two-day event will see Drs. Brian Durie (IMF), Ola Landgren (Memorial Sloan Kettering Cancer Center), Ken Anderson (Dana-Farber Cancer Institute), Sagar Lonial (Winship Cancer Institute), and James Hoffman (Sylvester Comprehensive Cancer Center) delivering presentations on hot myeloma topics including managing side effects, handling psychosocial issues, best therapies for elderly patients and patients with transplant, clinical trials and new drugs, and more. CLICK HERE for more information and/or to register for the event.


Replay of "What Patients Need to Know" Now Available


If you missed Dr. Durie’s “Best of ASH 2014: What Patients Need to Know” teleconference last week, you can now listen to the replay. In the presentation, Dr. Durie discusses the hot topics for all myeloma patients, including fine-tuning treatment based on specific characteristics, the role of MRD testing, new therapeutics, the new definition of early diagnosis, and more. CLICK HERE to listen to the replay.


New IMF Multiple Myeloma Patient Handbook Available to Download


One of the most daunting aspects of being diagnosed with myeloma is learning about – and understanding – an unfamiliar disease that is quite complicated. The updated 2015 edition of the IMF’s Patient Handbook provides an excellent overview of myeloma. Prepared by Dr. Durie, it focuses on what to do when myeloma is first discovered, the tests you really need, initial treatment options, and supportive care and how to get it. The Patient Handbook is meant to furnish you with the tools to understand and better manage your myeloma. Your caregivers, family, and friends may also find the information useful. CLICK HERE to download a copy of the handbook.


IMF Patient Bloggers Reflect on ASH 2014

Can you believe that the 56th Annual Meeting of the American Society of Hematology (ASH) was last year already? The IMF sent almost a dozen patient bloggers to cover the presentations, posters, and ceremonies. Now, they are wrapping up their experience with final “looking back on ASH” blogs to summarize what they learned and how they feel about the future of myeloma. CLICK HERE to read all of the ASH patient blogs.

Join Our Mailing List


12650 Riverside Drive, Suite 206 | North Hollywood, CA 91607-3421
IMF Hotline: 800-452-2873 or 818-487-7455
Privacy Policy | Unsubscribe

 related articles